Bernard Munos is Founder of InnoThink, a consultancy focused on translating innovation research into better business models for the pharma industry and its stakeholders, and Senior Fellow, FasterCures (A Center of the Milken Institute), an “action tank” focused on speeding the discovery and development of new therapies for severe diseases. Previously, Munos served at Merck in positions of increasing responsibility for nearly three decades. Bernard is author of ‘The Innovation Chatroom,’ a blog dedicated to biomedical innovation published in Forbes Magazine. Munos is a Member of the Advisory Council and the Cures Acceleration Network Review Boards of the National Center for Advancing Translational Sciences (NIH), and a Member of the Forum on Drug Discovery, Development and Translation, National Academy of Medicine. Munos has been named one of the 25 most influential people in biopharma by FiercePharma.